A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss [5]

Annals of Oncology

Volumn 18, Issue 1, 2007, Pages 201-202

  Santini, D ^a   Vincenzi, B ^a   Caraglia, M ^b   Tonini, G ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; CYTOKINE; ZOLEDRONIC ACID;

ACUTE PHASE RESPONSE; ADVANCED CANCER; ANAMNESIS; ARTHRALGIA; BREAST CANCER; CANCER PATIENT; CHILL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; FEVER; HUMAN; INCIDENCE; LETTER; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; TEMPERATURE MEASUREMENT;

ACUTE-PHASE REACTION; AROMATASE INHIBITORS; BONE DENSITY CONSERVATION AGENTS; BREAST NEOPLASMS; DIPHOSPHONATES; HUMANS; IMIDAZOLES; INCIDENCE; OSTEOPOROSIS;

EID: 33846514839     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl298     Document Type: Letter

References (8)

1. Adami S, Bhalla AK, Dorizzi R et al. The acute-phase response after bisphosphonate administration. Calcif Tissue Int 1987; 41: 326-331.
2. Dicuonzo G, Vincenzi B, Santini D et al. Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6. J Interferon Cytokine Res 2003; 23: 649-654.
3. Schweitzer DH, Oostendorp-van de Ruit M, Van der Pluijm G et al. Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate. J Bone Miner Res 1995; 10: 956-962.
4. Thiebaud D, Sauty A, Burckhardt P et al. An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int 1997; 61: 386-392.
5. Body JJ, Lichinitser M, Coleman RE, Bergstrom B. Oral ibandronate and intravenous zoledronic acid in metastatic breast cancer patients: comparative bone turnover marker and safety data. Bone 2006; 38 (Suppl 1): S69 (Abstr 68).
6. Kunzmann V, Bauer E, Wilhelm M. Gamma/delta T-cell stimulation by pamidronate. N Engl J Med 1999; 340: 737-738.
7. Kunzmann V, Bauer E, Feurle J et al. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000; 96: 384-392.
8. Thompson K, Rogers MJ. Statins prevent bisphosphonate-induced gamma, delta-T-cell proliferation and activation in vitro. J Bone Miner Res 2004; 19: 278-288.